Analyst consensus rating
OKYO Pharma Analyst Rating: Strong Buy
Direct answer
OKYO Pharma's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.33.
Forecast evidence checked October 17, 2026.
Get free OKYO Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $1.41
- Average price target
- $8.33
- High price target
- $13.00
- Low price target
- $5.00
- Low target gap
- +254.6%
- Target upside
- +491%
- High target gap
- +822%
- Target range width
- 567.4%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- October 17, 2026
- Valid through
- October 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for OKYO Pharma?
OKYO Pharma has a verified Strong Buy consensus. The same dataset has an average price target of $8.33.
How far are OKYO Pharma's low and high targets from the recorded price?
The low target implies +254.6%, while the high target implies +822%.
How many analysts are included in OKYO Pharma's consensus?
The verified consensus includes 3 analysts.
How is OKYO Pharma's target upside or downside calculated?
The average target of $8.33 is divided by the recorded price of $1.41, then one is subtracted to produce +491%. This does not guarantee a future return.
When was OKYO Pharma's analyst forecast verified?
The data was verified on 2026-10-17. The dataset is valid through 2026-10-24.